Scarica l'app Stockscreener
1.19
6.30%
-0.08
Dopo l'orario di chiusura:
1.20
0.01
+0.84%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PACB Giù?
Forum
Previsione
Pacific Biosciences Of California Inc Borsa (PACB) Ultime notizie
Customer success story: The University of Bern takes long-read sequencing to the next level with SPRQ chemistry - PacBio
Pacific Biosciences of California appoints CFO - MSN
PacBio names Jim Gibson as new CFO By Investing.com - Investing.com South Africa
Pacific Biosciences of California Names Jim Gibson CFO - Marketscreener.com
PacBio names Jim Gibson as new CFO - Investing.com India
Jim Gibson To Join PacBio As Chief Financial Officer - MarketScreener
Tech Giant CFO Who Raised $1B+ Joins PacBio: Ex-Tesla, Apple Executive to Drive Growth - Stock Titan
Publications March 2025 - Pacific Biosciences
Assessing Pacific Biosciences: Insights From 6 Financial Analysts - Benzinga
ATTENTION PACB SHAREHOLDERS: Investors Who Lost Money on Pacific Biosciences of California, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation - ACCESS Newswire
Here's Why You Should Retain PacBio Stock in Your Portfolio Now - MSN
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen - Benzinga
Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors - MSN
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now - MSN
PacBio, Take2 Resolve DNA Sequencing Patent Infringement Dispute - Bloomberg Law
Is Pacific Biosciences of California, Inc. (PACB) the Most Volatile Stock Under $3 For Day Trading? - Insider Monkey
10 Most Volatile Stocks Under $3 For Day Trading - Insider Monkey
Inspiring the next generation of scientists: How multidisciplinary science powers PacBio technology - Pacific Biosciences
Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks - The Globe and Mail
Pacific Biosciences of California (PACB) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance
ATTENTION PACB SHAREHOLDERS: Investors who lost money on Pacific Biosciences of California, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation - ACCESS Newswire
Pacific Biosciences secures extended lease with rent abatement By Investing.com - Investing.com Australia
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) - MSN
Pacific Biosciences secures extended lease with rent abatement - Investing.com
Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Re - GuruFocus
2024 SMRT Conserve grant winners - Pacific Biosciences
1 Healthcare Stock to Target This Week and 2 to Turn Down - The Globe and Mail
Pacific Biosciences of California, Inc. to Host Earnings Call - ACCESS Newswire
Selected publications from February 2025 - Pacific Biosciences
Pacific Biosciences COO Mark Van Oene sells $9,125 in company stock - Investing.com Australia
Pacific Biosciences CEO sells $17,583 in stock By Investing.com - Investing.com South Africa
Pacific Biosciences CEO sells $17,583 in stock - Investing.com
ARK Investment Management LLC Buys 2,637,961 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) - MarketBeat
Rare Disease Month: Putting People First - Pacific Biosciences
Pacific Biosciences of California (PACB) Stock Moves -1.18%: What You Should Know - MSN
Investor Network: Pacific Biosciences of California, Inc. to Host Earnings Call - ACCESS Newswire
Chromosome-level genome assembly and improved annotation of onion genome ( Allium cepa L.) - Nature.com
Pacific Biosciences: Uncertain Federal Research Funding Latest Blow For Already-Battered Stock - Seeking Alpha
Pacific Biosciences of California's (PACB) "Neutral" Rating Reaffirmed at Piper Sandler - MarketBeat
2.71%
0.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):